
Battling Cancer Using Rametrix® Urine Molecular Fingerprinting™
Cancer, a common and devastating disease process in both people and animals, can be difficult to detect until it is in relatively advanced stages –
We analyze liquids and develop actionable information, based on the molecular composition of the liquid. Our focus on molecular urinalysis has provided screening tools for important diseases, such as chronic kidney disease and cancer.

Cancer, a common and devastating disease process in both people and animals, can be difficult to detect until it is in relatively advanced stages –

As many as 1 in 7 Americans (more than 35 million people) have chronic kidney disease (CKD), especially those with diabetes and hypertension. About 90%

Today, RTI President John Robertson announced the spin-off of divisions that will focus separately on human and animal health problems and solutions to these problems.
Extensive studies of thousands of urine samples by Rametrix® Technologies, Inc. scientists and engineers, in collaboration with collaborating physicians and medical centers, have shown that serious health problems, like chronic kidney disease, can be quickly detected with Rametrix® Technologies, Inc. Molecular Urinalysis technology.